+

WO2004038003A3 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use Download PDF

Info

Publication number
WO2004038003A3
WO2004038003A3 PCT/US2003/033947 US0333947W WO2004038003A3 WO 2004038003 A3 WO2004038003 A3 WO 2004038003A3 US 0333947 W US0333947 W US 0333947W WO 2004038003 A3 WO2004038003 A3 WO 2004038003A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
compositions
polypeptides encoded
Prior art date
Application number
PCT/US2003/033947
Other languages
French (fr)
Other versions
WO2004038003A2 (en
Inventor
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Srinivas Kothakota
Haishan Lin
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Changjiang Zeng
Original Assignee
Five Prime Therapeutics Inc
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Srinivas Kothakota
Haishan Lin
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Changjiang Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Lewis T Williams, Keting Chu, Ernestine Lee, Kevin Hestir, Pierre Alvaro Beaurang, Dirk Behrens, Robert Forgan Halenbeck, Srinivas Kothakota, Haishan Lin, Thomas Linnemann, Kristen Pierce, Yan Wang, Justin G P Wong, Ge Wu, Hongbing Zhang, Changjiang Zeng filed Critical Five Prime Therapeutics Inc
Priority to AU2003298606A priority Critical patent/AU2003298606A1/en
Publication of WO2004038003A2 publication Critical patent/WO2004038003A2/en
Publication of WO2004038003A3 publication Critical patent/WO2004038003A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides novel polynucleotides, related polypeptides related nucleic acid and polypeptide compositions, and related modulators, such as antibodies and small molecule modulators. The invention also provides methods to make and use these polynucleotides, polypeptides, related compositions, and modulators. These methods include diagnostic, prophylactic and therapeutic applications. The compositions and methods of the invention are useful in treating proliferative disorders, e.g., cancers, and inflammatory, immune, bacterial, and viral disorders.
PCT/US2003/033947 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use WO2004038003A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003298606A AU2003298606A1 (en) 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use

Applications Claiming Priority (126)

Application Number Priority Date Filing Date Title
US42106102P 2002-10-25 2002-10-25
US42108002P 2002-10-25 2002-10-25
US42155202P 2002-10-25 2002-10-25
US42161402P 2002-10-25 2002-10-25
US60/421,552 2002-10-25
US60/421,061 2002-10-25
US60/421,614 2002-10-25
US60/421,080 2002-10-25
US42217802P 2002-10-30 2002-10-30
US42217702P 2002-10-30 2002-10-30
US60/422,177 2002-10-30
US60/422,178 2002-10-30
US42643002P 2002-11-15 2002-11-15
US42638402P 2002-11-15 2002-11-15
US42635502P 2002-11-15 2002-11-15
US42639402P 2002-11-15 2002-11-15
US42691602P 2002-11-15 2002-11-15
US60/426,355 2002-11-15
US60/426,394 2002-11-15
US60/426,430 2002-11-15
US60/426,916 2002-11-15
US60/426,384 2002-11-15
US42930202P 2002-11-27 2002-11-27
US42932602P 2002-11-27 2002-11-27
US42927502P 2002-11-27 2002-11-27
US42922402P 2002-11-27 2002-11-27
US42965102P 2002-11-27 2002-11-27
US60/429,326 2002-11-27
US60/429,302 2002-11-27
US60/429,224 2002-11-27
US60/429,275 2002-11-27
US60/429,651 2002-11-27
US43068402P 2002-12-04 2002-12-04
US43065702P 2002-12-04 2002-12-04
US43064502P 2002-12-04 2002-12-04
US43065102P 2002-12-04 2002-12-04
US43066802P 2002-12-04 2002-12-04
US43066302P 2002-12-04 2002-12-04
US60/430,651 2002-12-04
US60/430,657 2002-12-04
US60/430,663 2002-12-04
US60/430,645 2002-12-04
US60/430,684 2002-12-04
US60/430,668 2002-12-04
US43093702P 2002-12-05 2002-12-05
US43145802P 2002-12-05 2002-12-05
US43096502P 2002-12-05 2002-12-05
US60/431,458 2002-12-05
US60/430,937 2002-12-05
US60/430,965 2002-12-05
US43325102P 2002-12-12 2002-12-12
US43350002P 2002-12-12 2002-12-12
US60/433,251 2002-12-12
US60/433,500 2002-12-12
US43331602P 2002-12-13 2002-12-13
US43331802P 2002-12-13 2002-12-13
US60/433,316 2002-12-13
US60/433,318 2002-12-13
US43623602P 2002-12-23 2002-12-23
US60/436,236 2002-12-23
US43791403P 2003-01-03 2003-01-03
US60/437,914 2003-01-03
US44082103P 2003-01-17 2003-01-17
US44082003P 2003-01-17 2003-01-17
US60/440,821 2003-01-17
US60/440,820 2003-01-17
US46370003P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US46371603P 2003-04-18 2003-04-18
US60/463,716 2003-04-18
US60/463,708 2003-04-18
US60/463,700 2003-04-18
US60/463,732 2003-04-18
US46720103P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US46723003P 2003-05-02 2003-05-02
US46720303P 2003-05-02 2003-05-02
US60/467,203 2003-05-02
US60/467,201 2003-05-02
US60/467,230 2003-05-02
US60/467,199 2003-05-02
US47130603P 2003-05-19 2003-05-19
US47133603P 2003-05-19 2003-05-19
US60/471,306 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US47242003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US60/472,420 2003-05-22
US47660903P 2003-06-09 2003-06-09
US47662103P 2003-06-09 2003-06-09
US47664103P 2003-06-09 2003-06-09
US47663203P 2003-06-09 2003-06-09
US60/476,621 2003-06-09
US60/476,632 2003-06-09
US60/476,609 2003-06-09
US60/476,641 2003-06-09
US48532503P 2003-07-08 2003-07-08
US48535903P 2003-07-08 2003-07-08
US48522303P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US48521803P 2003-07-08 2003-07-08
US48521703P 2003-07-08 2003-07-08
US60/485,223 2003-07-08
US60/485,217 2003-07-08
US60/485,359 2003-07-08
US60/485,224 2003-07-08
US60/485,218 2003-07-08
US60/485,325 2003-07-08
US48644603P 2003-07-14 2003-07-14
US48648003P 2003-07-14 2003-07-14
US60/486,480 2003-07-14
US60/486,446 2003-07-14
US48696003P 2003-07-15 2003-07-15
US48689103P 2003-07-15 2003-07-15
US60/486,960 2003-07-15
US60/486,891 2003-07-15
US49337003P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US49357303P 2003-08-08 2003-08-08
US60/493,577 2003-08-08
US60/493,341 2003-08-08
US60/493,370 2003-08-08
US60/493,573 2003-08-08

Publications (2)

Publication Number Publication Date
WO2004038003A2 WO2004038003A2 (en) 2004-05-06
WO2004038003A3 true WO2004038003A3 (en) 2004-12-09

Family

ID=32180903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033947 WO2004038003A2 (en) 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country Link
AU (1) AU2003298606A1 (en)
WO (1) WO2004038003A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825328B1 (en) 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
JP5576010B2 (en) 2003-08-04 2014-08-20 ザ・ホスピタル・フォー・シック・チルドレン Lafora disease gene
US7910722B2 (en) * 2007-07-05 2011-03-22 Florida State University Research Foundation RNAi therapeutic for treatment of hepatitis C infection
GB201011819D0 (en) * 2010-07-14 2010-09-01 King S College London Neurodegenerative disorders
MX394682B (en) * 2016-05-11 2025-03-24 Amgen Inc DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETERODIMERIC PROTEINS USING INTRAGENIC GLUTAMINE SYNTHETASE COMPLEMENTATION VECTORS.
CN109142729B (en) * 2018-06-14 2021-04-23 郑州大学第一附属医院 A kind of lung cancer marker anti-HMGB3 autoantibody and its application
JP2022514116A (en) 2018-10-19 2022-02-09 ザ フランシス クリック インスティチュート リミティッド New cancer antigens and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075967A1 (en) * 2000-03-30 2001-10-11 Lam Research Corporation In situ and ex situ etching process for sti with oxide collar application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075967A1 (en) * 2000-03-30 2001-10-11 Lam Research Corporation In situ and ex situ etching process for sti with oxide collar application

Also Published As

Publication number Publication date
WO2004038003A2 (en) 2004-05-06
AU2003298606A8 (en) 2004-05-13
AU2003298606A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
WO2004035732A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004020595A8 (en) Novel human polypeptides encoded by polynucleotides
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2003080856A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2004038003A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2005085280A3 (en) HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
WO2004039952A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003031571A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2004046310A3 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004031354A3 (en) Human sarcoma-associated antigens
WO2004094598A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003085124A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载